Description
Product Overview
Sgltr-V Tablet is a combination of two active ingredients used in the management of type 2 diabetes mellitus. It is specifically designed for adults aged 18 years and older to improve blood glucose control, particularly when other diabetes medications have not been effective in achieving adequate glycemic control.
Sgltr-V Tablet can be prescribed on its own or alongside other diabetes treatments. It works best when used in combination with a healthy diet and regular physical activity. The tablet is typically taken twice daily, or as recommended by your doctor, to help control blood sugar levels and prevent complications associated with diabetes. It is important to take the medication consistently at the same time each day to maximize its benefits.
Salt Composition / Key Ingredients
- Remogliflozin Etabonate (100 mg): A sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps lower blood sugar by promoting the excretion of excess glucose through urine.
- Vildagliptin (50 mg): A DPP-4 inhibitor that works by increasing insulin secretion from the pancreas and reducing the production of glucose-raising hormones, helping to lower fasting and post-meal blood sugar levels.
How to Use Sgltr-V Tablet
- Dosage: Take Sgltr-V Tablet exactly as prescribed by your doctor. Typically, it is taken twice daily, with or without food. It is recommended to take the tablet at the same time each day for consistency.
- Administration: Swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet.
- Consistency: To get the most benefit, take the medicine regularly as part of a comprehensive diabetes management plan that includes diet and exercise.
How Sgltr-V Tablet Works
Sgltr-V Tablet contains two active ingredients that work together to control blood sugar levels:
- Remogliflozin Etabonate helps lower blood sugar by inhibiting the SGLT2 protein in the kidneys, which leads to the removal of excess glucose through urine.
- Vildagliptin works by increasing the release of insulin from the pancreas and reducing the levels of hormones that raise blood sugar (like glucagon). This results in lower fasting blood glucose levels and improved glucose control after meals.
Together, these medications help reduce blood sugar levels, which is essential in managing type 2 diabetes and preventing long-term complications.
Restrictions & Precautions
Before taking Sgltr-V Tablet, inform your doctor if you have a history of:
- Kidney disease, liver disease, or heart problems, as these conditions may affect how the medication works and your dosage.
- Pancreatic issues or a history of pancreatitis.
- Pregnancy or breastfeeding, as the safety of this medication during pregnancy and lactation should be discussed with your doctor.
- Alcohol consumption should be minimized, as alcohol can interfere with blood sugar control and may increase the risk of hypoglycemia (low blood sugar).
Additionally, tell your doctor about any other medications you are taking, especially those used for diabetes, as they may interact with Sgltr-V Tablet and cause changes in blood sugar levels.
Possible Side Effects of Sgltr-V Tablet
Most side effects are mild and may resolve as your body adjusts to the medication. However, some common side effects include:
- Diarrhea
- Nausea
- Headache
- Hypoglycemia (low blood sugar levels), especially if combined with other diabetes medications such as insulin or sulfonylureas
- Tremors
- Dizziness
- Weight gain
- Fever
- Cough
- Ketonuria (presence of ketones in urine)
- Constipation
- Dyslipidemia (abnormal cholesterol levels)
- Hypotension (low blood pressure)
- Weakness
- Urinary tract infections
- Respiratory tract infections
- Decreased kidney function (eGFR)
If any of these side effects persist or cause concern, consult your doctor. Regular monitoring of kidney function and blood glucose levels is recommended during treatment.
Marketed By
Mankind Pharma Ltd
